This is the authors' abstract. We don't add key points for this paper.
Starting from natural glutamine the synthesis of the 8aminomethylindolizine (4b) was accomplished.The construction of the ring system was performed by employing a cationic 6-exoπ-cyclization of an intermediate aziridinium salt.Transformation of the N,N-dibenzyl protected amine (4b) into the pharmacologically relevant target compound ( 11) is also describcd.The exploitation of cationic π-cyclizations in the construction of a variety of ring systems has been the object of intense studies in the field of heterocyclic chemistry. 1Employing N-pyrrole-terminated cyclization precursors this strategy gives access to tetrahydroindolizines and tetrahydropyrrolo[1 ,2-a]azepines. 2,3 As a part of our ongoing efforts to design selective dopamine D2/D3 autoreceptor agonists 4 which are of potential interest for the treatment of schizophrenia and cocaine craving, 5 we used cationic π-cyclizations for the construction of enantiomerically pure 6-and 7-dipropylaminotetrahydroindolizines revealing highly interesting receptor binding profiles. 6The ex-chiral pool synthesis of the 7-amino regioisomers was performed by chemoselective functionalization of asparagine (Asn), incorporation of a pyrrole moiety by Paal-Knorr reaction to furnish la and O-activation of the side chain. 7Since we were aware that sulfonylation of N,N-dibenzyl protected 1 ,2-amino alcohols and subsequent intermolecular nucleophilic substitution can result in rearrangements through aziridinium intermediates, 8 we elucidated the structure of the product very carefully.In fact, a 6-endo process leading to the indolizine (3a) was observed exclusively.5-Exo attack of 2a to give the pyrrolizine derivative (4a) could not bc detected.As an extension of our studies, we intended to investigate the synthesis of the homologous 1 ,2-amino alcohol (1b) which should bc available from natural glutamine (Gln).After O-activation the cyclization behavior of the resulting aziridinium derivative (2b) should be examined.
No takes yet. Share an insight, caveat, or question.
Gmeiner et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: